Concepedia

Jeffrey Strovel

JS

13

Publications

392

Citations

12

H-Index

1999

Active since

Affiliations

University of Maryland, Baltimore(Current)

National Center for Advancing Translational Sciences

Convergent Engineering (United States)

Kyoto Prefectural University of Medicine

Kyoto University Hospital

Jeffrey Strovel is an author at University of Maryland, Baltimore specializing in medicine, cell biology, and drug discovery.

Top concepts

MedicineCell BiologyPharmacologyDrug DiscoveryTumor BiologyDrug DevelopmentMedicinal ChemistryImmunologyCancer BiologyCell Signaling

Publications per year

1999–2021

13

Publications

13

BRD4 Structure–Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536

Lijia Chen, Jeremy L. Yap, Makoto Yoshioka et al. · ACS Medicinal Chemistry Letters · 2015 · 89 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Focused Library +15

Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies

Jeffrey Strovel, Sitta Sittampalam, Nathan P. Coussens et al. · 2016 · 57 citations

Drug Repositioning, Oncology, Drug Target +15

Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth

Ahmed A. Mohamed, Charles P. Xavier, Gauthaman Sukumar et al. · Cancer Research · 2018 · 55 citations

AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model

Hisayuki Yao, Eishi Ashihara, Jeffrey Strovel et al. · Blood Cancer Journal · 2011 · 48 citations · Full text

Hematological Malignancy, Novel Therapy, Medicine +13

Binding of HMG-I(Y) elicits structural changes in a silencer of the human ?-globin gene

Michael B. Chase, Susanne B. Haga, W. David Hankins et al. · American Journal of Hematology · 1999 · 25 citations · Full text

Rows per page

1–5 of 13